These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3068492)

  • 41. Purification of alpha and beta subunits and subunit pairs from rat liver mitochondrial F1-ATPase.
    Williams N; Pedersen PL
    Methods Enzymol; 1986; 126():484-9. PubMed ID: 2908462
    [No Abstract]   [Full Text] [Related]  

  • 42. Variable factors influencing the production of tetanus toxin.
    MUELLER JH; MILLER PA
    J Bacteriol; 1954 Mar; 67(3):271-7. PubMed ID: 13142991
    [No Abstract]   [Full Text] [Related]  

  • 43. Production, purification, and assay of Clostridium perfringens enterotoxin.
    McDonel JL; McClane BA
    Methods Enzymol; 1988; 165():94-103. PubMed ID: 2906731
    [No Abstract]   [Full Text] [Related]  

  • 44. Tetanus toxin production is triggered by the transition from amino acid consumption to peptides.
    Licona-Cassani C; Steen JA; Zaragoza NE; Moonen G; Moutafis G; Hodson MP; Power J; Nielsen LK; Marcellin E
    Anaerobe; 2016 Oct; 41():113-124. PubMed ID: 27492724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective levels of tetanus toxin can be made in a production medium totally lacking both animal (e.g., brain heart infusion) and dairy proteins or digests (e.g., casein hydrolysates).
    Demain AL; Gerson DF; Fang A
    Vaccine; 2005 Nov; 23(46-47):5420-3. PubMed ID: 16122852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purification of tetanus toxin with the aid of Sephadex gels.
    Salenstedt CR; Tirunarayanan MO
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Feb; 130(2):190-6. PubMed ID: 4231551
    [No Abstract]   [Full Text] [Related]  

  • 47. [Enhancement of toxin production and sporogenesis in Cl. tetani 471 cultures under the influence of endogenous metabolites].
    Korovina VP; Chikishev EV; Vaĭsman ISh
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):102-6. PubMed ID: 795225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EFFECTS OF PRODUCTS OF HEAT DEGRADATION OF GLUCOSE ON GROWTH AND ON FORMATION OF SOLUBLE ANTIGENS OF CLOSTRIDIUM TETANI. I.
    LETTL A; NEKVASILOVA K; MORAVEC K; PETERA A; STEJSKAL A
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():301-6. PubMed ID: 14187347
    [No Abstract]   [Full Text] [Related]  

  • 49. Participation of peptides in tetanus toxin production.
    MUELLER JH; MILLER PA
    Trans N Y Acad Sci; 1953 Nov; 16(1):20-3. PubMed ID: 13169220
    [No Abstract]   [Full Text] [Related]  

  • 50. Increasing color density with decreasing toxicity of tetanus toxin in the Mueller medium.
    STONE JL
    Appl Microbiol; 1953 May; 1(3):160-1. PubMed ID: 13041192
    [No Abstract]   [Full Text] [Related]  

  • 51. [Characteristic properties of Clostridium tetani Harvard A-47].
    Kiritani K; Ueda S; Nishida S
    Igaku To Seibutsugaku; 1968 Jul; 77(1):27-31. PubMed ID: 4883106
    [No Abstract]   [Full Text] [Related]  

  • 52. Investigation of the tetanus toxin from two different strains of Clostridium tetani.
    LARGIER JF
    J Immunol; 1956 Jun; 76(6):393-8. PubMed ID: 13332240
    [No Abstract]   [Full Text] [Related]  

  • 53. Purification and properties of human platelet P235: talin.
    Collier NC; Wang K
    Methods Enzymol; 1992; 215():99-109. PubMed ID: 1435346
    [No Abstract]   [Full Text] [Related]  

  • 54. Growth and toxin production of Tetanus bacilli in vivo.
    Smith JW; MacIver AG
    J Med Microbiol; 1974 Nov; 7(4):497-504. PubMed ID: 4615153
    [No Abstract]   [Full Text] [Related]  

  • 55. Purification of Escherichia coli DNA polymerase III holoenzyme.
    Cull MG; McHenry CS
    Methods Enzymol; 1995; 262():22-35. PubMed ID: 8594350
    [No Abstract]   [Full Text] [Related]  

  • 56. [Growing Clostridium on nutritional media with polyacrylamide gel].
    Bil'ko IP
    Mikrobiol Zh (1978); 1986; 48(4):88-91. PubMed ID: 2908416
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies of the amino acid transformation of the liquid 10-day-old culture of Clostridium tetani. I. Growing of Clostridium tetani, obtaining of filtrates and purification of the biological material].
    Klimek J
    Ann Univ Mariae Curie Sklodowska Med; 1965; 20():29-33. PubMed ID: 5334737
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of medium composition on the production of tetanus toxin by Clostridium tetani.
    Fratelli F; Siquini TJ; Prado SM; Higashi HG; Converti A; de Carvalho JC
    Biotechnol Prog; 2005; 21(3):756-61. PubMed ID: 15932253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Production of tetanolysin preparations and characteristics of their properties].
    Shabarov IA; Rumiantsev SN; Pospelov VF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):3-6. PubMed ID: 3898671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous production of Clostridium tetani toxin.
    Zacharias B; Björklund M
    Appl Microbiol; 1968 Jan; 16(1):69-72. PubMed ID: 4865906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.